试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-05-03
A Study of DeTIL-0255 in Adults With Advanced Malignancies
编号:NCT05107739登记状态:提前终止企业 / 申办者:Nurix Therapeutics, Inc.
药物 / 成分:Drug Product De-TIL-0255
登记的停止原因(原文):Sponsor Decision
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-05-02
Phase 1/2 Prospective Double-Blind Placebo-Controlled Randomized Clinical Trial of Losartan to Treat Grade II & III Hamstring Strains
编号:NCT02263729登记状态:提前终止企业 / 申办者:James J. Irrgang
药物 / 成分:Losartan、Placebo
登记的停止原因(原文):The study was terminated due to difficulty identifying eligible participants and the expiration of funding.
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-05-02
QUILT-3.009: Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC)
编号:NCT02465957登记状态:提前终止企业 / 申办者:ImmunityBio, Inc.
药物 / 成分:aNK (NK-92)、aNK (NK-92) + N-803
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-05-02
A Study of Rivoceranib and Trifluridine/Tipiracil for Metastatic Colorectal Cancer (mCRC)
编号:NCT04073615登记状态:提前终止企业 / 申办者:Elevar Therapeutics
药物 / 成分:Rivoceranib、Trifluridine/Tipiracil
登记的停止原因(原文):Phase 2 portion of the study was not performed due to redirection of the rivoceranib development plan by the Sponsor.
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-05-02
Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen
编号:NCT04346615登记状态:提前终止企业 / 申办者:Pfizer
药物 / 成分:Zavegepant (BHV-3500)、Placebo
登记的停止原因(原文):Lack of enrollment due to evolution of COVID-19 pandemic with reduction in patients at risk for severe disease and growing number of effective alternative therapies
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-05-02
A First Time in Human (FTIH) Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GSK3884464 in Healthy Participants
编号:NCT05044325登记状态:提前终止企业 / 申办者:GlaxoSmithKline
药物 / 成分:GSK3884464、Placebo
登记的停止原因(原文):To allow for additional assessments from supplementary non-clinical activities.
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-05-02
A Trial of Neoadjuvant Therapy in Patients With Newly Diagnosed Glioblastoma
编号:NCT05074992登记状态:提前终止企业 / 申办者:University College, London
药物 / 成分:Ipilimumab
登记的停止原因(原文):Support withdrawn from drug company supplying IMP
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-05-02
Treatment of Eosinophilic Chronic Rhinosinusitis Utilizing Betamethasone Dipropionate Nasal Cream
编号:NCT05220293登记状态:提前终止企业 / 申办者:Oticara Australia PTY LTD
药物 / 成分:Betamethasone Dipropionate Nasal Cream 0.0644%、Pre-filled syringe and applicator device
登记的停止原因(原文):Single site study OT-007 re-opened as multi-site OT-007B study
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-05-02
Voxelotor Neurocognitive Function Study
编号:NCT05228834登记状态:提前终止企业 / 申办者:Pfizer
药物 / 成分:Voxelotor Only Product in Oral Dose Form、Placebo
登记的停止原因(原文):Data will not inform further development of Voxelotor
查看官方原始记录 ↗试验终止ClinicalTrials.gov(美国登记平台)来源日期:2024-05-02
The Effect of Chemoradiotherapy on Gastric Perfusion in Patients With Gastric Cancer.
编号:NCT05354856登记状态:提前终止企业 / 申办者:Copenhagen University Hospital, Rigshospitalet
药物 / 成分:Indocyanine green
登记的停止原因(原文):recruiting issues
查看官方原始记录 ↗